Insiders / Ray Prudo, M.D.
Ray Prudo, M.D.
CIK 1653262unknownbeneficial ownerinsider
Companies
1
First seen
Jan 2, 2024
Last activity
Mar 4, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Celsus Therapeutics Plc. · AKTX | 4,916,600,800 | — |
All securities held
6 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Celsus Therapeutics Plc. | Ordinary shares | 4,916,600,800 |
| Celsus Therapeutics Plc. | Depositary shares | 2,904,728 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Celsus Therapeutics Plc. | Class A options | 446,428 |
| Celsus Therapeutics Plc. | Class B options | 446,428 |
| Celsus Therapeutics Plc. | Warrants | 386,661 |
| Celsus Therapeutics Plc. | Options | 225,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | Grant Grant or award | AKTX Celsus Therapeutics Plc. Ordinary Shares, par value $0.0001 per share | $503.1K | +419.3M +11.46% | 4,077,124,600 4.45% of shares | low |
| Mar 6, 2025 | Grant Grant or award | AKTX Celsus Therapeutics Plc. American Depositary Shares representing Ordinary Shares | $500.0K | +446K +21.90% | 2,484,990 <0.01% of shares | low |
| Mar 6, 2025 | Grant Grant or award | AKTX Celsus Therapeutics Plc. |